Syneron Medical Ltd (ELOS) Tops Q1 Estimates
Get Alerts ELOS Hot Sheet
Join SI Premium – FREE
Syneron Medical Ltd (NASDAQ: ELOS) reported Q1 EPS of ($0.07), $0.08 better than the analyst estimate of ($0.15). For Q1, Non-GAAP net income per share attributable to Syneron shareholders operations before non-controlling interest came out to $0.02 profit.
Revenue for the quarter came in at $62.66 million versus the consensus estimate of $55.91 million.
For earnings history and earnings-related data on Syneron Medical Ltd (ELOS) click here.
Revenue for the quarter came in at $62.66 million versus the consensus estimate of $55.91 million.
For earnings history and earnings-related data on Syneron Medical Ltd (ELOS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BayCom Corp (BCML) Misses Q1 EPS by 4c
- Five Point Holdings, LLC (FPH) Reports Q1 EPS of $0.03
- P.A.M. Transportation Services (PTSI) Misses Q1 EPS by 9c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!